4-1171044-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_012445.4(SPON2):āc.591C>Gā(p.Phe197Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000387 in 1,549,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 34)
Exomes š: 7.2e-7 ( 0 hom. )
Consequence
SPON2
NM_012445.4 missense
NM_012445.4 missense
Scores
5
9
2
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
SPON2 (HGNC:11253): (spondin 2) Predicted to enable antigen binding activity; lipopolysaccharide binding activity; and metal ion binding activity. Predicted to be involved in cell adhesion. Predicted to act upstream of or within several processes, including defense response to other organism; opsonization; and positive regulation of cytokine production. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.869
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPON2 | NM_012445.4 | c.591C>G | p.Phe197Leu | missense_variant | 4/6 | ENST00000290902.10 | NP_036577.2 | |
SPON2 | NM_001128325.3 | c.591C>G | p.Phe197Leu | missense_variant | 5/7 | NP_001121797.2 | ||
SPON2 | NM_001199021.2 | c.591C>G | p.Phe197Leu | missense_variant | 6/8 | NP_001185950.2 | ||
LOC124900647 | XM_047416477.1 | c.-2486-20056G>C | intron_variant | XP_047272433.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
5
AN:
152216
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 7.16e-7 AC: 1AN: 1396846Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 688850
GnomAD4 exome
AF:
AC:
1
AN:
1396846
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
688850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152334Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74500
GnomAD4 genome
AF:
AC:
5
AN:
152334
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.591C>G (p.F197L) alteration is located in exon 6 (coding exon 3) of the SPON2 gene. This alteration results from a C to G substitution at nucleotide position 591, causing the phenylalanine (F) at amino acid position 197 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;D
Vest4
MutPred
Loss of glycosylation at S193 (P = 0.0309);Loss of glycosylation at S193 (P = 0.0309);Loss of glycosylation at S193 (P = 0.0309);
MVP
MPC
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at